Monoclonal antibody | |
---|---|
Type | Whole antibody |
Source | Humanized (from mouse) |
Target | SOST |
Clinical data | |
Pregnancy cat. | ? |
Legal status | ? |
Identifiers | |
CAS number | 1132758-87-2 |
ATC code | None |
Chemical data | |
Formula | C6462H9852N1684O2030S46 |
Mol. mass | 144.63 kDa |
(verify) |
(what is this?)
Blosozumab binds SOST, a negative regulator of osteoblast activity. Blocking SOST activity can lead to increased bone density.[1]
Blosozumab was developed by Eli Lilly and Company.
|